Serum (1,3)-b-D-Glucan for Screening of Neonatal Fungemia.
Indian Pediatr
; 59(6): 499-500, 2022 06 15.
Article
em En
| MEDLINE
| ID: mdl-35695143
ABSTRACT
This study was conducted to identify the mycological pattern, and to calculate the diagnostic accuracy of serum (1,3)-b-D-glucan for screening fungal sepsis in 351 high-risk neonates. Candida tropicalis was the most common isolate (n=16, 38.1%). At optimum cut-off (47.2 pg/mL), sensitivity and specificity of serum (1,3)-b-D-glucan were 92.9% and 69.9%, respectively.
Buscar no Google
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Fungemia
/
Beta-Glucanas
Tipo de estudo:
Diagnostic_studies
/
Prognostic_studies
/
Screening_studies
Limite:
Humans
/
Newborn
Idioma:
En
Revista:
Indian Pediatr
Ano de publicação:
2022
Tipo de documento:
Article